Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 known ✓ | P41145 | 1/20 | 0.49 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.46 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.46 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 6/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | PTPRB | P23467 | 1/20 | 0.53 |
| ▸ | CDC25A | P30304 | 1/20 | 0.53 |
| ▸ | CDC25B | P30305 | 1/20 | 0.53 |
| ▸ | PTEN | P60484 | 1/20 | 0.53 |
| ▸ | PTPMT1 | Q8WUK0 | 1/20 | 0.53 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL65250 | 0.93 | KEAP1 (0.63) | FFAR1KEAP1PTPRBCDC25ACDC25B | |
| SCHEMBL29563859 | 0.93 | KEAP1 (0.63) | FFAR1KEAP1PTPRBCDC25ACDC25B | |
| SCHEMBL31336237 | 0.93 | KEAP1 (0.63) | FFAR1KEAP1PTPRBCDC25ACDC25B | |
| Phenyl Propionic Acid SCHEMBL29282176 | 0.89 | KEAP1 (0.70) | FFAR1KEAP1PTPRBCDC25ACDC25B | |
| SCHEMBL29185406 | 0.86 | FFAR1 (0.56) | FFAR1KEAP1PTPRBCDC25ACDC25B | |
| SCHEMBL30825091 | 0.86 | FFAR1 (0.56) | FFAR1KEAP1PTPRBCDC25ACDC25B | |
| SCHEMBL3717612 | 0.82 | HDAC6 (0.66) | FFAR1KEAP1MGLLDRD2DRD1 | |
| SCHEMBL70271 | 0.81 | KEAP1 (0.74) | FFAR1KEAP1PTPRBCDC25ACDC25B | |
| SCHEMBL1049248 | 0.81 | HDAC6 (0.67) | MGLLDRD2DRD1TAAR1HDAC6 | |
| SCHEMBL30303107 | 0.81 | HDAC6 (0.67) | MGLLDRD2DRD1TAAR1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3965820-A1 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | The Regents of the University of California (US) | 2022-03-16 | — | — | EP | claimed |
| WO-2020226683-A1 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-11-12 | — | — | WO | claimed |
| US-20200138894-A1 | FLAVONOID COMPOSITIONS AND METHODS OF USE | BERKLEY, LLC | 2020-05-07 | — | — | US | claimed |
| US-10441621-B2 | Flavonoid compositions and methods of use | REOXCYN, LLC (US) | 2019-10-15 | — | — | US | claimed |
| US-20170106036-A1 | FLAVONOID COMPOSITIONS AND METHODS OF USE | BERKLEY, LLC | 2017-04-20 | — | — | US | claimed |
| US-12274730-B2 | Flavonoid compositions and methods of use | BERKLEY, LLC (US) | 2025-04-15 | — | — | US | disclosed |
| US-11894139-B1 | Disease spectrum classification | PATIENTSLIKEME LLC (US) | 2024-02-06 | — | — | US | disclosed |
| US-20230371552-A1 | Pet Food Compositions | HILL'S PET NUTRITION, INC. (US) | 2023-11-23 | — | — | US | disclosed |
| EP-3965820-A1 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | The Regents of the University of California (US) | 2022-03-16 | — | — | EP | disclosed |
| US-20210386816-A1 | FLAVONOID COMPOSITIONS AND METHODS OF USE | BERKLEY, LLC | 2021-12-16 | — | — | US | disclosed |
| US-11004539-B2 | Predicting metabolic side effects of transported drugs | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-05-11 | — | — | US | disclosed |
| US-10953064-B2 | Flavonoid compositions and methods of use | BERKLEY, LLC (US) | 2021-03-23 | — | — | US | disclosed |
| WO-2020226683-A1 | COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-11-12 | — | — | WO | disclosed |
| US-20200230193-A1 | FLAVONOID COMPOSITIONS AND METHODS OF USE | BERKLEY, LLC | 2020-07-23 | — | — | US | disclosed |
| US-20200138894-A1 | FLAVONOID COMPOSITIONS AND METHODS OF USE | BERKLEY, LLC | 2020-05-07 | — | — | US | disclosed |
| US-10441621-B2 | Flavonoid compositions and methods of use | REOXCYN, LLC (US) | 2019-10-15 | — | — | US | disclosed |
| CN-108603859-A | Method for diagnosing disease using metabolites in urine | 株式会社日立制作所 | 2018-09-28 | — | — | CN | disclosed |
| US-20170241043-A1 | PREDICTING METABOLIC SIDE EFFECTS OF TRANSPORTED DRUGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-08-24 | — | — | US | disclosed |
| US-20170106036-A1 | FLAVONOID COMPOSITIONS AND METHODS OF USE | BERKLEY, LLC | 2017-04-20 | — | — | US | disclosed |